These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27178549)

  • 1. Evaluation of inhibition of miRNA expression induced by anti-miRNA oligonucleotides.
    Chae DK; Ban E; Yoo YS; Baik JH; Song EJ
    Anal Bioanal Chem; 2016 Jul; 408(18):4829-33. PubMed ID: 27178549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-nucleotide Modification of Anti-miRNA Oligonucleotides.
    Lennox KA; Vakulskas CA; Behlke MA
    Methods Mol Biol; 2017; 1517():51-69. PubMed ID: 27924473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective Anti-miRNA Oligonucleotides Show High Releasing Rate of MicroRNA from RNA-Induced Silencing Complex.
    Ariyoshi J; Matsuyama Y; Kobori A; Murakami A; Sugiyama H; Yamayoshi A
    Nucleic Acid Ther; 2017 Oct; 27(5):303-308. PubMed ID: 28876213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous detection of multiple microRNAs for expression profiles of microRNAs in lung cancer cell lines by capillary electrophoresis with dual laser-induced fluorescence.
    Ban E; Chae DK; Song EJ
    J Chromatogr A; 2013 Nov; 1315():195-9. PubMed ID: 24094482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of micro-RNA in cardiomyoblast cells using CE with LIF detection.
    Ban E; Chae DK; Song EJ
    Electrophoresis; 2013 Feb; 34(4):598-604. PubMed ID: 23192357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient and specific inhibition of plant microRNA function by anti-microRNA oligonucleotides (AMOs) in vitro and in vivo.
    He L; Xie M; Huang J; Zhang T; Shi S; Tang T
    Plant Cell Rep; 2016 Apr; 35(4):933-45. PubMed ID: 26792284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-miRNA oligonucleotides: A comprehensive guide for design.
    Lima JF; Cerqueira L; Figueiredo C; Oliveira C; Azevedo NF
    RNA Biol; 2018 Mar; 15(3):338-352. PubMed ID: 29570036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative relationship between chemical properties and bioactivities of anti-microRNA oligonucleotides targeted to tumor-associated microRNA-21.
    Nagahama K; Iseda K; Kawano D; Kawakami J
    Biochimie; 2017 Jun; 137():124-131. PubMed ID: 28302473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different chemically modified inhibitors of miR-199b in vivo.
    Duygu B; Juni R; Ottaviani L; Bitsch N; Wit JBM; de Windt LJ; da Costa Martins PA
    Biochem Pharmacol; 2019 Jan; 159():106-115. PubMed ID: 30452907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical modification and design of anti-miRNA oligonucleotides.
    Lennox KA; Behlke MA
    Gene Ther; 2011 Dec; 18(12):1111-20. PubMed ID: 21753793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of anti-miRNA oligonucleotides (AMOs) on A549 cell growth.
    Fei J; Lan F; Guo M; Li Y; Liu Y
    J Drug Target; 2008 Nov; 16(9):688-93. PubMed ID: 18982517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference.
    Lu Y; Xiao J; Lin H; Bai Y; Luo X; Wang Z; Yang B
    Nucleic Acids Res; 2009 Feb; 37(3):e24. PubMed ID: 19136465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative microRNA detection from precursor-microRNA-transfected hepatocellular carcinoma cells by capillary electrophoresis with dual-color laser-induced fluorescence.
    Yang TH; Ou DL; Hsu C; Huang SH; Chang PL
    Electrophoresis; 2012 Sep; 33(17):2769-76. PubMed ID: 22965724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of microRNAs in vivo with 'antagomirs'.
    Krützfeldt J; Rajewsky N; Braich R; Rajeev KG; Tuschl T; Manoharan M; Stoffel M
    Nature; 2005 Dec; 438(7068):685-9. PubMed ID: 16258535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Anti-miR Pharmacology with miRNA Polysome Shift Assay.
    Androsavich JR
    Methods Mol Biol; 2017; 1517():103-113. PubMed ID: 27924477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A direct comparison of anti-microRNA oligonucleotide potency.
    Lennox KA; Behlke MA
    Pharm Res; 2010 Sep; 27(9):1788-99. PubMed ID: 20424893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of 2,6-Diaminopurines into Serinol Nucleic Acid Improves Anti-miRNA Performance.
    Kamiya Y; Donoshita Y; Kamimoto H; Murayama K; Ariyoshi J; Asanuma H
    Chembiochem; 2017 Oct; 18(19):1917-1922. PubMed ID: 28748559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
    Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
    Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a dual-luciferase reporter system for in vivo visualization of MicroRNA biogenesis and posttranscriptional regulation.
    Lee JY; Kim S; Hwang DW; Jeong JM; Chung JK; Lee MC; Lee DS
    J Nucl Med; 2008 Feb; 49(2):285-94. PubMed ID: 18199619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.